Substance P and its metabolites in normal human tears.

PURPOSE To determine amounts and biochemical characteristics of substance P-like immunoreactivity (SPLI) in tears of normal human subjects. METHODS Forty-three healthy subjects (16 males and 27 females; age range, 17-80 years) participated. Ten microliters of unstimulated tears were collected with a micropipette from one eye of all subjects. Tear samples were partially purified by C-18 cartridges. SPLI concentrations in purified samples were measured by enzyme immunoassay (EIA). For biochemical characterization of SPLI, tear extracts were fractionated by high-performance liquid chromatography (HPLC). Each fraction then was subjected to EIA. To determine the metabolism of substance P in tears, synthetic substance P was incubated in medium containing pooled tears and then analyzed by HPLC with the detector set at a 210-nm wavelength. RESULTS The SPLI concentration in normal human tears was 306.0 +/- 96.5 pg/mL (mean +/- SD; range, 148-555 pg/mL). SPLI did not significantly vary by age or gender. HPLC analysis indicated that SPLI in tears consisted of five different substances and that substance P was converted to several fragments, including SP(8-11) by enzymes present in tears. CONCLUSIONS Substance P, a normal component of human tears, presumably is released from the nerve endings in the ocular surface and converted to fragments by degradative enzymes in tears.

[1]  M. Yamada,et al.  Decreased substance P concentrations in tears from patients with corneal hypesthesia. , 2000, American journal of ophthalmology.

[2]  T. Chikama,et al.  Synergistic effect with Phe‐Gly‐Leu‐Met‐NH2 of the C‐terminal of substance P and insulin‐like growth factor‐1 on epithelial wound healing of rabbit cornea , 1999, British journal of pharmacology.

[3]  K. Fukuda,et al.  Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I , 1998, The Lancet.

[4]  T. Chikama,et al.  Up-regulation of integrin alpha 5 expression by combination of substance P and insulin-like growth factor-1 in rabbit corneal epithelial cells. , 1998, Biochemical and biophysical research communications.

[5]  W. Tourtellotte,et al.  Development and Evaluation of a Chromatographic Procedure for Partial Purification of Substance P with Quantitation by an Enzyme Immunoassay , 1998, Clinical Diagnostic Laboratory Immunology.

[6]  C. Marfurt,et al.  Peptidergic innervation of the rat cornea. , 1998, Experimental eye research.

[7]  C. Murphy,et al.  [Neurotrophic keratopathy--studies on substance P and the clinical significance of corneal sensation]. , 1997, Nippon Ganka Gakkai zasshi.

[8]  R. Beuerman,et al.  Detection of substance P in human tears by laser desorption mass spectrometry and immunoassay. , 1997, Current eye research.

[9]  C. Murphy,et al.  Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. , 1997, Archives of ophthalmology.

[10]  K. Tsubota,et al.  Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  T. Chikama,et al.  Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo. , 1997, Current eye research.

[12]  C. Murphy,et al.  Synergistic effects of substance P with insulin‐like growth factor‐1 on epithelial migration of the cornea , 1996, Journal of cellular physiology.

[13]  K. Rissler.  Sample preparation, high-performance liquid chromatographic separation and determination of substance P-related peptides. , 1995, Journal of chromatography. B, Biomedical applications.

[14]  C. Belmonte,et al.  Neurotrophic influences on corneal epithelial cells. , 1994, Experimental eye research.

[15]  C. Murphy,et al.  Stimulation of epithelial cell growth by the neuropeptide substance P , 1993, Journal of cellular biochemistry.

[16]  M. A. Pozo,et al.  Effects of capsaicin on corneal wound healing. , 1990, Investigative ophthalmology & visual science.

[17]  B. Malfroy,et al.  Recombinant enkephalinase effectively inhibits substance P-induced miosis in the rabbit eye cup model. , 1990, Current eye research.

[18]  J. Lehtosalo.  Substance P-like immunoreactive trigeminal ganglion cells supplying the cornea , 2004, Histochemistry.

[19]  F. Tsuji,et al.  Tachykinins as enhancers of prostaglandin E2-induced intraocular inflammation. , 1998, Ocular immunology and inflammation.

[20]  C. Maggi,et al.  In vivo pupillary constrictor effects of substance P in man. , 1991, Life sciences.

[21]  I. Iwamoto,et al.  Inhibitory effect of tranilast on substance P-induced plasma extravasation in rat skin. , 1991, Immunopharmacology and immunotoxicology.

[22]  H. Cramer,et al.  High-performance liquid chromatographic separation of tachykinins using Tris-phosphate as the buffer component of the mobile phase. , 1990, Journal of chromatography.

[23]  A. Cuello,et al.  Substance P immunoreaction and acetylcholinesterase activity in the cornea and Gasserian ganglion. , 1983, Ophthalmic research.